Anthony Akkari

Anthony Akkari is a Visiting Professor affiliated with the University of Western Australia (UWA) Medical School and the Centre for Neuromuscular and Neurological Disorders (Perron Institute). His research focuses on neurological disorders, pharmacogenetics, and molecular biology, particularly in areas like Amyotrophic Lateral Sclerosis (ALS) and anorexia nervosa. He has contributed to over 50 peer-reviewed publications, including studies on antidepressant pharmacotherapy optimization and novel therapeutic approaches for neurodegenerative diseases.

Recent work highlights include exploring barriers to antidepressant use in youth through focus groups and thematic analysis, investigating allele-selective therapies for ALS using antisense oligonucleotides, and applying nanopore sequencing to identify anorexia nervosa risk loci. His research aligns with UN Sustainable Development Goals related to good health and well-being.

He led a grant-funded project on protein binding partners in motor neurone disease, demonstrating his commitment to translational research. Collaborations span institutions globally, particularly in neurology and genetics. No awards are explicitly listed, though his high citation count (1,584) reflects impactful contributions.